← Back to Search

Behavioural Intervention

Strategies for Substance Use Disorder (STUN II Trial)

N/A
Recruiting
Led By Daniel E Jonas, MD, MPH
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

Summary

This trial aims to compare different strategies for improving substance use disorder screening and interventions in primary care settings. They will enroll 144 clinic staff participants from 48 primary care practices to evaluate the effectiveness of practice

Who is the study for?
This trial is for staff at primary care practices who are involved in screening and interventions for substance use disorders. It's not specified who can't join, but typically those with conflicts of interest or inability to participate fully might be excluded.
What is being tested?
The STUN II Trial is testing four strategies to improve handling of substance use disorders in primary care: practice facilitation (PF), PF with a learning collaborative (LC), PF with performance incentives (PI), and the combination of all three methods.
What are the potential side effects?
Since this trial involves implementation strategies rather than medications, traditional side effects aren't expected. However, there may be indirect effects on clinic workflow or staff stress levels.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Number of adults referred to specialty care for alcohol use disorder
Number of adults referred to specialty care for substance use disorder and/or alcohol use disorder
Number of adults screened for substance use disorder
+24 more
Other study objectives
Association between implementation effectiveness and putative moderators and mediators

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Practice Facilitation + Performance IncentivesExperimental Treatment2 Interventions
Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Performance Incentives: Practices will receive a maximum total of $6,000 based on their performance during the 12-month implementation period. They will have the opportunity to receive up to $1,500 per quarter if they reach performance milestones for the quarter.
Group II: Practice Facilitation + Learning Collaborative + Performance IncentivesExperimental Treatment3 Interventions
Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Learning Collaborative (LC): Virtual LC sessions will be held monthly and will include participants presenting anonymized cases to clinical experts, targeted brief didactics related to the content of the cases, and time for open discussion and Q\&A. Performance Incentives: Practices will receive a maximum total of $6,000 based on their performance during the 12-month implementation period. They will have the opportunity to receive up to $1,500 per quarter if they reach performance milestones for the quarter.
Group III: Practice Facilitation + Learning CollaborativeExperimental Treatment2 Interventions
Practice Facilitation (PF): Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months. Learning Collaborative (LC): Virtual LC sessions will be held monthly and will include participants presenting anonymized cases to clinical experts, targeted brief didactics related to the content of the cases, and time for open discussion and Q\&A.
Group IV: Practice Facilitation OnlyActive Control1 Intervention
Practice Facilitation: Practices will receive up to 2 hours of direct practice facilitation services per month for 12 months.

Find a Location

Who is running the clinical trial?

Ohio Association of Community Health Centers (OACHC)UNKNOWN
Ohio State UniversityLead Sponsor
859 Previous Clinical Trials
642,621 Total Patients Enrolled
3 Trials studying Alcoholism
345 Patients Enrolled for Alcoholism
Agency for Healthcare Research and Quality (AHRQ)FED
405 Previous Clinical Trials
6,756,521 Total Patients Enrolled
3 Trials studying Alcoholism
432 Patients Enrolled for Alcoholism
~96 spots leftby Sep 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top